News from Tokyo Headquarters

Fujifilm launches FUJINON HP66×15.2-ESM and FUJINON HP12×7.6ERD-S9

Fujifilm and the Center for Advanced Biological Innovation and Manufacturing Announce 76 million USD in Funding for Manufacturing and Innovation Center

Fujifilm launches “FUJINON Premista19-45mmT2.9”

Fujifilm to Invest Over 200 Billion yen (2 Billion USD) to Establish New Large-Scale Cell Culture Manufacturing Site for Biopharmaceuticals in the U.S.A.

Fujifilm to invest $40 Million to Establish a New State-of-the-Art Viral Vector and Advanced Therapy Process Development and Manufacturing Facility

Fujifilm develops technology to deliver the world’s highest 580TB storage capacity^*1 for magnetic tapes using strontium ferrite (SrFe) magnetic particles

FUJIFILM Cellular Dynamics and Lonza
agree to expand the availability and use of induced pluripotent stem cell technology

FUJIFILM Diosynth Biotechnologies Stands Ready to Manufacture Lilly COVID-19 Antibody for Low- and Middle-Income Countries

Fujifilm to Expand its Viral Vector CDMO Services to Europe

Fujifilm launches FUJINON HYPER-CLARITY Series of binoculars with a bright and clear field of view

Fujifilm wins Good Design Award with 27 products in a wide range of business fields

Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation

Fujifilm’s ultra-short throw projector and image-stabilized binoculars win Gold Award in the internationally-prestigious U.S. design award, IDEA

Fujifilm launches FUJINON Premista19-45mmT2.9

FUJIFILM Diosynth Biotechnologies expands its partnership with Novavax to manufacture COVID-19 Vaccine Candidate at its Billingham site

FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing

Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate 

Fujifilm develops “FUJIFILM PROJECTOR Z8000”

Fujifilm develops high-performance multispectral camera system

Fujifilm to invest 100 billion yen (928 million USD) to expand its large scale biologics production facility in Denmark